Notably TP53, which is inactivated by mutations in 47 of the NCI-60 [3], [32] (our submitted results) has focal loss in only two cell lines LE:HL_60, RE:TK_10 (Table S3), demonstrating specificity in mechanism of function knockdown of tumor suppressors. This evidence concerns the gene TP53 and neoplasm.